Interferon Alfacon-1 and Ribavirin Versus Interferon α-2b and Ribavirin in the Treatment of Chronic Hepatitis C

By Sjogren Maria   Sjogren Robert   Holtzmuller Kent   Winston Bradley   Butterfield Betty   Drake Stanley   Watts Amber   Howard Robin   Smith Milton  

Digestive Diseases and Sciences, Vol. 50, Iss. 4, 2005-04 ,pp. : 727-732

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C

By Younossi Zobair   McCullough Arthur   Barnes David   Post Anthony   Ong Janus   O’shea Robert   Martin Lisa   Bringman Diane   Farmer Denise   Levinthal Gavin   Mullen Kevin   Carey William   Tavill Anthony   Ferguson Roy   Gramlich Terry  

Digestive Diseases and Sciences, Vol. 50, Iss. 5, 2005-05 ,pp. : 970-975

Springer Publishing Company

Access to resources Recommend Favorite

Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment

By Mathew A.   Peiffer L.   Rhoades K.   McGarrity T.  

Digestive Diseases and Sciences, Vol. 51, Iss. 11, 2006-11 ,pp. : 1956-1961

Springer Publishing Company

Access to resources Recommend Favorite

A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C

By Okuse Chiaki   Adachi Kayo   Katakura Yoshiki   Matsunaga Kotaro   Ishii Toshiya   Matsumoto Nobuyuki   Yotsuyanagi Hiroshi   Iino Shiro   Suzuki Michihiro   Itoh Fumio  

Journal of Gastroenterology, Vol. 41, Iss. 12, 2006-12 ,pp. : 1231-1236

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Benefits and Cost-Effectiveness of 17-Year Treatment with Low-Dose Interferon-α 2b in a Patient with Chronic Hepatitis C: A Case Report

By Kawaguchi Takumi   Sumie Shuji   Itou Minoru   Taniguchi Eitaro   Matoba Tsunetaka   Sata Michio  

Digestive Diseases and Sciences, Vol. 54, Iss. 3, 2009-03 ,pp. : 690-694

Springer Publishing Company

Access to resources Recommend Favorite